Literature DB >> 33255021

Chitosan/PEGDA based scaffolds as bioinspired materials to control in vitro angiogenesis.

Alessandra Soriente1, Soledad Pérez Amodio2, Ines Fasolino1, Maria Grazia Raucci3, Christian Demitri4, Elisabeth Engel2, Luigi Ambrosio1.   

Abstract

In the current work, our purpose was based on the assessment of bioactive chitosan (CS)/Poly(ethylene glycol) diacrylate (PEGDA) based scaffolds ability to stimulate in vitro angiogenesis process. The bioactivation of the scaffolds was accomplished by using organic (BMP-2 peptide) and inorganic (hydroxyapatite nanoparticles) cues. In particular, the properties of the materials in terms of biological response promotion on human umbilical vein endothelial cells (HUVECs) were studied by using in vitro angiogenesis tests based on cell growth and proliferation. Furthermore, our interest was to examine the scaffolds capability to modulate two important steps involved in angiogenesis process: migration and tube formation of cells. Our data underlined that bioactive signals on CS/PEGDA scaffolds surface induce a desirable effect on angiogenic response concerning angiogenic marker expression (CD-31) and endothelial tissue formation (tube formation). Taken together, the results emphasized the concept that bioactive CS/PEGDA scaffolds may be novel implants for stimulating neovascularization of tissue-engineered constructs in regenerative medicine field.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; BMP-2 peptide; Chitosan/PEGDA based scaffolds; Human umbilical vein endothelial cells HUVECs; Osteogenesis

Mesh:

Substances:

Year:  2020        PMID: 33255021     DOI: 10.1016/j.msec.2020.111420

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  1 in total

1.  Chitosan/hydroxyapatite nanocomposite scaffolds to modulate osteogenic and inflammatory response.

Authors:  Alessandra Soriente; Ines Fasolino; Alejandro Gomez-Sánchez; Evgen Prokhorov; Giovanna Giuliana Buonocore; Gabriel Luna-Barcenas; Luigi Ambrosio; Maria Grazia Raucci
Journal:  J Biomed Mater Res A       Date:  2021-07-31       Impact factor: 4.854

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.